Barclays

Barclays’s Trevi Therapeutics TRVI Stock Holding History

Barclays’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$639K	Sell	53,585 -529,068	-91%	-$5.92M	﹤0.01%	3039
2025 Q4	$7.29M	Buy	582,653 +365,768	+169%	+$4.23M	﹤0.01%	1930
2025 Q3	$1.98M	Sell	216,885 -298,591	-58%	-$2.24M	﹤0.01%	2888
2025 Q2	$2.82M	Buy	515,476 +377,544	+274%	+$2.35M	﹤0.01%	2581
2025 Q1	$868K	Sell	137,932 -18,335	-12%	-$87.5K	﹤0.01%	3191
2024 Q4	$644K	Buy	156,267 +61,035	+64%	+$195K	﹤0.01%	3665
2024 Q3	$318K	Buy	95,232 +61,317	+181%	+$182K	﹤0.01%	4050
2024 Q2	$101K	Sell	33,915 -1,280	-4%	-$3.56K	﹤0.01%	3899
2024 Q1	$121K	Sell	35,195 -28,602	-45%	-$63.8K	﹤0.01%	4360
2023 Q4	$85.5K	Buy	63,797 +50,512	+380%	+$76.5K	﹤0.01%	4672
2023 Q3	$29K	Sell	13,285 -767	-5%	-$1.73K	﹤0.01%	4069
2023 Q2	$33.6K	Buy	+14,052	New	+$35.4K	﹤0.01%	4002
2021 Q4	–	Sell	-100	Closed	–	–	4738
2021 Q3	$0	Hold	100	–	–	﹤0.01%	5018
2021 Q2	$0	Buy	+100	New	+$225	﹤0.01%	5082
2020 Q3	–	Sell	-15	Closed	–	–	5581
2020 Q2	$0	Buy	+15	New	+$53	﹤0.01%	6232

Other funds holding TRVI

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return